Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Features of Impacted Common Bile Duct Stones at Duodenal Papilla.
Lee JM, Lee SH, Kim JH, Kim TS, Chang SH, Kim SH, Lee JH, Kang CD, Park JM. Lee JM, et al. Among authors: kim ts, kim sh, kim jh. Korean J Gastroenterol. 2024 Dec 25;84(6):274-281. doi: 10.4166/kjg.2024.099. Korean J Gastroenterol. 2024. PMID: 39716949 Free article.
Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
Kim JH, Kang SH, Lee M, Choi HS, Jun BG, Kim TS, Choi DH, Suk KT, Kim MY, Kim YD, Cheon GJ, Baik SK, Kim DJ. Kim JH, et al. Among authors: kim ts, kim dj, kim yd, kim my. J Gastroenterol Hepatol. 2020 Oct;35(10):1795-1803. doi: 10.1111/jgh.15046. Epub 2020 Apr 20. J Gastroenterol Hepatol. 2020. PMID: 32222111
Capsule Endoscopy for Gastric Evaluation.
Kim JH, Nam SJ. Kim JH, et al. Diagnostics (Basel). 2021 Sep 28;11(10):1792. doi: 10.3390/diagnostics11101792. Diagnostics (Basel). 2021. PMID: 34679491 Free PMC article. Review.
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka T, Gerolami R, Ikeda M, Kumada H, El-Khoueiry AB, Vogel A, Peng X, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS, Llovet JM; LEAP-012 investigators. Kudo M, et al. Among authors: kim jh. Lancet. 2025 Jan 8:S0140-6736(24)02575-3. doi: 10.1016/S0140-6736(24)02575-3. Online ahead of print. Lancet. 2025. PMID: 39798578
32,345 results
You have reached the last available page of results. Please see the User Guide for more information.